In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

EAPCI President's Address



The European Association of Percutaneous Cardiovacsular Interventions (EAPCI) has now more than 7,400 members from 133 countries. Since its foundation in 2006 EAPCI developed a very dynamic and productive structure driven by the leadership of highly dedicated individuals.

As a result of the 2016 elections, a new Board has been constituted by our members and it will be my privilege to lead the Association for the term May 2016 to May 2018 with the support of Andreas Baumbach as President-Elect, Stephan Windecker as Past-President, Bernard Chevalier as Treasurer, Giulio Guagliumi as Secretary , Patrick Serruys as Editor-in-Chief of EuroIntervention, and the two appointed PCR Board representatives Christoph Naber and Bernard Prendergast.

During the upcoming term 2016-2018, I will focus with the support of the Board and the different committees on the following objectives based on the EAPCI long-term strategy of established throughout the last years:

Strengthen the scientific visibility of EAPCI

Interventional cardiovascular medicine has contributed immensely to improve patient outcome. As in previous years, the Association will further excel scientific knowledge and standards in several ways:

  • To continuously deliver scientific consensus and position documents on relevant topics in interventional cardiovascular medicine
  • To assist to obtain European research funding support
  • To provide a networking platform for clinical research partnership

Keep valvular heart disease interventions a key priority of the Association

Transcatheter valve interventions with their recent most important advances have significantly contributed to the field of cardiovascular medicine. Most recently, the Valve for Life initiative has been established by EAPCI to broaden the use of this interventional technology according to recent guideline recommendations. This project has been started successfully in two pilot countries (Poland and France) and will help to facilitate adoption of this new technology across Europe, very similar to what has been achieved with primary PCI for STEMI in the Stent for Life initiative. In addition, the Association will continue to advance this subspecialty in numerous ways:

  • To participate in educational platforms such as PCR London Valves
  • To cooperate with other Associations such as EHRA, EACVI, HFA and the Working Group on Valvular Heart Disease to provide the highest standard of care to affected patients

Raise educational standards in interventional cardiovascular medicine

The prolific development in several domains including coronary interventions, transcatheter heart valve interventions, structural heart disease interventions, neurohumoral denervation and interventional pharmacology pose an increasing responsibility to provide a common ground of knowledge and expertise. The Association aims to further raise educational standards by

  • Continued development of the ESC eLearning platform
  • Establishment of a regular European interventional cardiovascular fellows course
  • Provision of training and research grants for young interventional cardiology fellows
  • Involvement of nurses and allied professions in the training process

Address gender differences in access, care and outcome

The Association has successfully established a dedicated EAPCI Women Committee that has already put lots of effort in the field of gender issues in interventional cardiology and will continue to do so in collaboration with several other EAPCI committees.

Focus on the young interventional cardiovascular community

We continuously need to invest in the upcoming and future interventional cardiovascular community in order to attract the most talented individuals into our subspecialty. The Association has implemented the very active and productive Young Committee which will continue to develop specific initiatives such as CathGO adapted to the needs of young interventional cardiologists in training.

New EAPCI constitution and membership levels

In the near future, and as all other ESC Associations, we will have to vote on a new EAPCI constitution adapted to the ESC Statutes to ensure cohesion as a whole, facilitate internal ESC governance. In this broad context, a new inclusive membership programme with different membership levels will be established with different levels of benefits of high value to the interventional community.

Finally, in a more complicated environment of getting sponsorship, the EAPCI Executive Board will continuously put lots of effort into fund raising in order to actively proceed all of these projects.

Professor Michael Haude
President of the European Association of Percutaneous
Cardiovascular Interventions (EAPCI)
2016-2018